Brainstorm Cell Therapeutics Inc. Stock Deutsche Boerse AG
Equities
GHDN
US10501E2019
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.465 EUR | -5.01% | -6.44% | +102.17% |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 36.88M 34.53M 50.7M |
---|---|---|---|---|---|
Net income 2024 * | -21M -19.66M -28.87M | Net income 2025 * | -27M -25.28M -37.12M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.93
x | P/E ratio 2025 * |
-1.44
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.75% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -5.01% | ||
1 week | -6.44% | ||
Current month | -9.71% | ||
1 month | -31.31% | ||
3 months | +58.16% | ||
6 months | +290.76% | ||
Current year | +102.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change |
---|---|---|
24-04-30 | 0.465 | -5.01% |
24-04-29 | 0.4895 | +0.62% |
24-04-26 | 0.4865 | -2.31% |
24-04-25 | 0.498 | +3.53% |
24-04-24 | 0.481 | -3.22% |
Delayed Quote Deutsche Boerse AG, April 30, 2024 at 06:17 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.52% | 42.86B | |
+12.19% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.73% | 25.15B | |
-23.80% | 18.63B | |
+27.97% | 12.37B | |
-3.61% | 11.92B | |
+7.00% | 11.21B |
- Stock Market
- Equities
- BCLI Stock
- GHDN Stock